Replies to post #15 on TScan Therapeutics Inc (TCRX)

[jondoeuk]

The company will host a webcast on Thurs, May 19, at 4:30 p.m. ET. The event will provide a summary of the ASGCT posters and oral presentation as well as a discussion of the solid tumour programs. The featured speaker will be Kai Wucherpfennig, M.D., Ph.D., Chair, Cancer Immunology and Virology and Director, Center for Cancer Immunology Research at the Dana-Farber Cancer Institute, Professor of Neurology, Brigham and Women’s Hospital and Harvard Medical School, and Associate Member, Broad Institute of MIT and Harvard. The presentation will be followed by a question-and-answer session.